HistCite - The sequence of the human genome (Venter)

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
4201	1653 Savage SA, Chanock S Genetic variation and hematopoietic stem cell transplantation: expansion of the paradigm PEDIATRIC TRANSPLANTATION. 2003; 7: 32-39	0	0	3	40
4202	2453 Estephan R, Arevalo E, Becker JM, Naider F Biosynthesis of the sixth transmembrane domain of the Saccharomyces cerevisiae alpha-factor receptor PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS. 2004; : 754-755	0	0	2	7
4203	835 Conlon JM The origin and evolution of peptide YY (PYY) and pancreatic polypeptide (PP) PEPTIDES. 2002 FEB; 23 (2): 269-278	1	37	1	90
4204	3375 Hand D, Eiden LE Human sorbin is generated via splicing of an alternative transcript from the ArgBP2 gene locus PEPTIDES. 2005 JUL; 26 (7): 1278-1282	0	0	2	14
4205	4409 Pimenta DC, Lebrun I Cryptides: Buried secrets in proteins PEPTIDES. 2007 DEC; 28 (12): 2403-2410	0	4	2	56
4206	909 Curlin M, Kostovic-Knezevic L, Gajovic S Gene trap mutagenesis of three genes expressed during mouse embryo development PERIODICUM BIOLOGORUM. 2002 MAR; 104 (1): 47-54	0	5	2	30
4207	2766 Plohl M, Bruvo B, Mestrovic N, Mravinac B, Petrovic V, et al. Satellite DNA sequences in centromeric heterochromatin PERIODICUM BIOLOGORUM. 2004 JUN; 106 (2): 95-102	1	3	4	94
4208	3543 Zinic SD SitaRam: a computational approach for multi perspective visualization of higher-order and progressive patterns in highly repetitive regions of DNA PERIODICUM BIOLOGORUM. 2005 DEC; 107 (4): 423-436	0	1	8	50
4209	703 Schenkein HA Finding genetic risk factors for periodontal diseases: is the climb worth the view? PERIODONTOLOGY 2000. 2002; 30: 79-90	0	18	2	86
4210	3635 Slavkin HC, Bartold PM Challenges and potential in tissue engineering PERIODONTOLOGY 2000. 2006; 41: 9-15	0	8	7	64
#	Date / Author / Journal	LCS	GCS	LCR	CR
4211	3813 White TJ, Clark AG, Broder S Genome-based biomarkers for adverse drug effects, patient enrichment and prediction of drug response, and their incorporation into clinical trial design PERSONALIZED MEDICINE. 2006 MAY; 3 (2): 177-185	0	4	3	31
4212	4310 Subbiab MTR Personalizing our diet to improve our health: the potential impact of nutrigenomics PERSONALIZED MEDICINE. 2007 AUG; 4 (3): 233-236	0	0	3	56
4213	4549 Farrell E, Usuka J Pharmacogenomics and drug development: the impact of US FDA postapproval tracking on clinical pharmacology PERSONALIZED MEDICINE. 2008 MAR; 5 (2): 133-139	0	0	2	33
4214	5107 Wagner MJ Pharmacogenetics and personal genomes PERSONALIZED MEDICINE. 2009 NOV; 6 (6): 643-652	0	1	9	65
4215	380 Gest H Evolution of knowledge encapsulated in scientific definitions PERSPECTIVES IN BIOLOGY AND MEDICINE. 2001 FAL; 44 (4): 556-564	0	2	2	28
4216	1390 Hunter P, Robbins P, Noble D The IUPS human physiome project PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY. 2002 OCT; 445 (1): 1-9	7	39	1	34
4217	3268 Soutourina O, Cheval L, Doucet A Global analysis of gene expression in mammalian kidney PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY. 2005 APR; 450 (1): 13-25	0	4	8	73
4218	1530 Chin KV, Kong ANT Application of DNA Microarrays in pharmacogenomics and toxicogenomics PHARMACEUTICAL RESEARCH. 2002 DEC; 19 (12): 1773-1778	5	26	2	30
4219	1716 Anderle P, Rakhmanova V, Woodford K, Zerangue N, Sadee W Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines PHARMACEUTICAL RESEARCH. 2003 JAN; 20 (1): 3-15	4	22	1	34
4220	556 Freimuth RR, Eckloff B, Wieben ED, Weinshilboum RM Human sulfotransferase SULT1C1 pharmacogenetics: gene resequencing and functional genomic studies PHARMACOGENETICS. 2001 DEC; 11 (9): 747-756	1	30	2	34
#	Date / Author / Journal	LCS	GCS	LCR	CR
4221	757 Xu ZH, Freimuth RR, Eckloff B, Wieben E, Weinshilboum RM Human 3 '-phosphoadenosine 5 '-phosphosulfate synthetase 2 (PAPSS2) pharmacogenetics: gene resequencing, genetic polymorphisms and functional characterization of variant allozymes PHARMACOGENETICS. 2002 JAN; 12 (1): 11-21	1	16	2	38
4222	1717 Liljedahl U, Karlsson J, Melhus H, Kurland L, Lindersson M, et al. A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response PHARMACOGENETICS. 2003 JAN; 13 (1): 7-17	2	37	2	33
4223	2502 Nelson DR, Zeldin DC, Hoffman SMG, Maltais LJ, Wain HM, et al. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants PHARMACOGENETICS. 2004 JAN; 14 (1): 1-18	1	194	5	52
4224	2767 Tetlow N, Robinson A, Mantle J, Board P Polymorphism of human mu class glutathione transferases PHARMACOGENETICS. 2004 JUN; 14 (6): 359-368	0	16	1	81
4225	2860 Hillman MA, Wilke RA, Caldwell MD, Berg RL, Glurich I, et al. Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype PHARMACOGENETICS. 2004 AUG; 14 (8): 539-547	1	43	2	83
4226	3335 Busi F, Cresteil T Phenotyping-genotyping of alternatively spliced genes in one step: study of CYP3A5*3 polymorphism PHARMACOGENETICS AND GENOMICS. 2005 JUN; 15 (6): 433-439	0	6	5	30
4227	3544 Gratz M, Kunert-Keil C, John U, Cascorbi I, Kroemer HK Identification and functional analysis of genetic variants of the human beta-glucuronidase in a German population sample PHARMACOGENETICS AND GENOMICS. 2005 DEC; 15 (12): 875-881	0	2	1	25
4228	4792 Krzywkowski K, Davies PA, Irving AJ, Brauner-Osborne H, Jensen AA Characterization of the effects of four HTR3B polymorphisms an human 5-HT3AB receptor expression and signalling PHARMACOGENETICS AND GENOMICS. 2008 DEC; 18 (12): 1027-1040	0	1	2	38
4229	242 Sham P Shifting paradigms in gene-mapping methodology for complex traits PHARMACOGENOMICS. 2001 AUG; 2 (3): 195-202	1	10	2	66
4230	243 Huang S Genomics, complexity and drug discovery: insights from Boolean network models of cellular regulation PHARMACOGENOMICS. 2001 AUG; 2 (3): 203-222	5	35	3	91
#	Date / Author / Journal	LCS	GCS	LCR	CR
4231	758 Shilling PD, Kelsoe JR Functional genomics approaches to understanding brain disorders PHARMACOGENOMICS. 2002 JAN; 3 (1): 31-45	1	21	2	96
4232	910 Dandekar T, Sauerborn R Comparative genome analysis and pathway reconstruction PHARMACOGENOMICS. 2002 MAR; 3 (2): 245-256	0	10	6	64
4233	911 Pettipher R, Cardon LR The application of genetics to the discovery of better medicines PHARMACOGENOMICS. 2002 MAR; 3 (2): 257-263	0	12	2	36
4234	1063 Judson R, Salisbury B, Schneider J, Windemuth A, Stephens JC How many SNPs does a genome-wide haplotype map require? PHARMACOGENOMICS. 2002 MAY; 3 (3): 379-391	7	50	5	46
4235	1064 Balasubramanian S, Harrison P, Hegyi H, Bertone P, Luscombe N, et al. SNPs on human chromosomes 21 and 22 - analysis in terms of protein features and pseudogenes PHARMACOGENOMICS. 2002 MAY; 3 (3): 393-402	2	8	5	49
4236	1330 Thallinger GG, Trajanoski S, Stocker G, Trajanoski Z Information management systems for pharmacogenomics PHARMACOGENOMICS. 2002 SEP; 3 (5): 651-667	0	2	5	61
4237	1331 Obata K, Tajima H, Yohda M, Matsunaga T Recent developments in laboratory automation using magnetic particles for genome analysis PHARMACOGENOMICS. 2002 SEP; 3 (5): 697-708	0	9	1	30
4238	1454 Willett JD Genomics, proteomics: what's next PHARMACOGENOMICS. 2002 NOV; 3 (6): 727-728	0	2	2	15
4239	1455 Dixon AK, Lee K, Richardson PJ, Bell MI, Skynner MJ Single cell expression analysis - pharmacogenomic potential PHARMACOGENOMICS. 2002 NOV; 3 (6): 809-822	0	6	3	83
4240	1837 Slavkin HC Applications of pharmacogenomics in general dental practice PHARMACOGENOMICS. 2003 MAR; 4 (2): 163-170	1	3	3	41
#	Date / Author / Journal	LCS	GCS	LCR	CR
4241	2195 Hoehe MR Haplotypes and the systematic analysis of genetic variation in genes and genomes PHARMACOGENOMICS. 2003 SEP; 4 (5): 547-570	1	20	5	106
4242	2943 Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, et al. Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population PHARMACOGENOMICS. 2004 OCT; 5 (7): 895-931	2	76	3	48
4243	3244 Yengi LG Systems biology in drug safety and metabolism: integration of microarray, real-time PCR and enzyme approaches PHARMACOGENOMICS. 2005 MAR; 6 (2): 185-192	1	7	2	67
4244	3269 Lorenzi C, Mandelli L, Pirovano A, Ploia C, Insacco C, et al. The XIIth World Congress of Psychiatric Genetics PHARMACOGENOMICS. 2005 APR; 6 (3): 199-204	0	0	2	18
4245	3336 Bennett ST, Barnes C, Cox A, Davies L, Brown C Toward the $1000 human genome PHARMACOGENOMICS. 2005 JUN; 6 (4): 373-382	8	58	7	40
4246	4126 Kimchi-Sarfaty C, Marple AH, Shinar S, Kimchi AM, Scavol D, et al. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene PHARMACOGENOMICS. 2007 JAN; 8 (1): 29-39	0	12	1	56
4247	4234 Crawford DC, Ritchie MD, Rieder MJ Identifying the genotype phenotype: a role model behind the found in VKORC1 and its association with warfarin dosing PHARMACOGENOMICS. 2007 MAY; 8 (5): 487-496	1	10	5	84
4248	4268 Lal S, Wong ZW, Jada SR, Xiang XQ, Shu XC, et al. Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients PHARMACOGENOMICS. 2007 JUN; 8 (6): 567-575	0	11	2	30
4249	4385 Gurwitz D, Motulsky AG 'Drug reactions, enzymes, and biochemical genetics': 50 years later PHARMACOGENOMICS. 2007 NOV; 8 (11): 1479-1484	0	7	3	31
4250	4520 Oertel B, Lotsch J Genetic mutations that prevent pain: implications for future pain medication PHARMACOGENOMICS. 2008 FEB; 9 (2): 179-194	0	13	2	113
#	Date / Author / Journal	LCS	GCS	LCR	CR
4251	4605 Zhang W, Dolan ME Ancestry-related differences in gene expression: findings may enhance understanding of health disparities between populations PHARMACOGENOMICS. 2008 MAY; 9 (5): 489-492	1	2	4	35
4252	4924 Wang HH, Liao YW, Chiang HL, Wu JY, Chen YT Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population PHARMACOGENOMICS. 2009 MAR; 10 (3): 359-374	0	0	2	34
4253	4925 Gennari L, Merlotti D, De Paola V, Martini G, Nuti R Update on the pharmacogenetics of the vitamin D receptor and osteoporosis PHARMACOGENOMICS. 2009 MAR; 10 (3): 417-433	0	0	2	132
4254	4977 Gagna CE, Lambert WC Novel multistranded, alternative, plasmid and helical transitional DNA and RNA microarrays: implications for therapeutics PHARMACOGENOMICS. 2009 MAY; 10 (5): 895-914	0	1	9	62
4255	5086 Abdel-Hamid IA, Andersson KE Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications PHARMACOGENOMICS. 2009 OCT; 10 (10): 1625-1644	0	0	5	174
4256	1654 Scherl E, Frissora CL Irritable bowel syndrome genophenomics: correlation of serotonin-transporter polymorphisms and alosetron response PHARMACOGENOMICS JOURNAL. 2003; 3 (2): 64-66	0	4	2	16
4257	1655 Chen X, Sullivan PF Single nucleotide polymorphism genotyping: biochemistry, protocol, cost and throughput PHARMACOGENOMICS JOURNAL. 2003; 3 (2): 77-96	4	66	6	134
4258	3478 Freebern WJ, Haggerty CM, Montano I, McNutt MC, Collins I, et al. Pharmacologic profiling of transcriptional targets deciphers promoter logic PHARMACOGENOMICS JOURNAL. 2005 OCT; 5 (5): 305-323	1	5	2	69
4259	3814 Farahani P, Levine M Pharmacovigilance in a genomic era PHARMACOGENOMICS JOURNAL. 2006 MAY; 6 (3): 158-161	0	3	3	47
4260	3945 Weiss ST, Litonjua AA, Lange C, Lazarus R, Liggett SB, et al. Overview of the pharmacogenetics of asthma treatment PHARMACOGENOMICS JOURNAL. 2006 SEP-OCT; 6 (5): 311-326	0	27	3	105
#	Date / Author / Journal	LCS	GCS	LCR	CR
4261	4901 Passetti F, Ferreira CG, Costa FF The impact of microRNAs and alternative splicing in pharmacogenomics PHARMACOGENOMICS JOURNAL. 2009 FEB; 9 (1): 1-13	0	2	4	134
4262	2661 Meloni R, Khalfallah O, Biguet NF DNA microarrays and pharmacogenomics PHARMACOLOGICAL RESEARCH. 2004 APR; 49 (4): 303-308	1	9	7	44
4263	2662 Trotta R, Donati MB, Iacoviello L Trends in pharmacogenomics of drugs acting on hypertension PHARMACOLOGICAL RESEARCH. 2004 APR; 49 (4): 351-356	0	7	1	75
4264	4333 Kim HR, Park SW, Cho HJ, Chae KA, Sung JM, et al. Comparative gene expression profiles of intestinal transporters in mice, rats and humans PHARMACOLOGICAL RESEARCH. 2007 SEP; 56 (3): 224-236	0	10	4	108
4265	4902 de Leon J The future (or lack of future) of personalized prescription in psychiatry PHARMACOLOGICAL RESEARCH. 2009 FEB; 59 (2): 81-89	0	6	7	91
4266	912 Schrem H, Klempnauer J, Borlak J Liver-enriched transcription factors in liver function and development. Part I: The hepatocyte nuclear factor network and liver-specific gene expression PHARMACOLOGICAL REVIEWS. 2002 MAR; 54 (1): 129-158	0	93	1	261
4267	2196 Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y Impact of drug transporter studies on drug discovery and development PHARMACOLOGICAL REVIEWS. 2003 SEP; 55 (3): 425-461	1	169	3	387
4268	3245 Kreek MJ, Bart G, Lilly C, Laforge KS, Nielsen DA Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments PHARMACOLOGICAL REVIEWS. 2005 MAR; 57 (1): 1-26	1	83	4	300
4269	244 Yuan J, Liu Y, Wang YH, Xie GC, Blevins R Genome analysis with gene-indexing databases PHARMACOLOGY & THERAPEUTICS. 2001 AUG; 91 (2): 115-132	2	9	2	64
4270	836 Davies TG, Pratt DJ, Endicott JA, Johnson LN, Noble MEM Structure-based design of cyclin-dependent kinase inhibitors PHARMACOLOGY & THERAPEUTICS. 2002 FEB-MAR; 93 (2-3): 125-133	0	50	1	44
#	Date / Author / Journal	LCS	GCS	LCR	CR
4271	837 Yeh RH, Lee TR, Lawrence DS From consensus sequence to high-affinity ligands: acquisition of signaling protein modulators PHARMACOLOGY & THERAPEUTICS. 2002 FEB-MAR; 93 (2-3): 179-191	0	2	1	42
4272	2143 Carroll PM, Dougherty B, Ross-Macdonald P, Browman K, FitzGerald K Model systems in drug discovery: chemical genetics meets genomics PHARMACOLOGY & THERAPEUTICS. 2003 AUG; 99 (2): 183-220	0	22	7	340
4273	2718 Roth BL, Lopez E, Beischel S, Westkaemper RB, Evans JM Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery PHARMACOLOGY & THERAPEUTICS. 2004 MAY; 102 (2): 99-110	3	30	6	65
4274	2768 Kostenis E A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands PHARMACOLOGY & THERAPEUTICS. 2004 JUN; 102 (3): 243-257	2	26	2	162
4275	3337 Krause CD, Pestka S Evolution of the Class 2 cytokines and receptors, and discovery of new friends and relatives PHARMACOLOGY & THERAPEUTICS. 2005 JUN; 106 (3): 299-346	0	35	5	206
4276	3407 Efferth T, Volm M Pharmacogenetics for individualized cancer chemotherapy PHARMACOLOGY & THERAPEUTICS. 2005 AUG; 107 (2): 155-176	2	62	5	289
4277	3479 Roth BL Receptor systems: Will mining the receptorome yield novel targets for pharmacotherapy? PHARMACOLOGY & THERAPEUTICS. 2005 OCT; 108 (1): 59-64	0	2	6	67
4278	3815 Millan MJ Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application PHARMACOLOGY & THERAPEUTICS. 2006 MAY; 110 (2): 135-370	0	86	15	3729
4279	3889 Judge SI, Bever CT Potassium channel blockers in multiple sclerosis: Neuronal K-V channels and effects of symptomatic treatment PHARMACOLOGY & THERAPEUTICS. 2006 JUL; 111 (1): 224-259	0	39	1	429
4280	5087 Horstmann S, Binder EB Pharmacogenomics of antidepressant drugs PHARMACOLOGY & THERAPEUTICS. 2009 OCT; 124 (1): 57-73	0	1	3	226
#	Date / Author / Journal	LCS	GCS	LCR	CR
4281	4709 Tretter F, Albus M Systems biology and psychiatry - Modeling molecular and cellular networks of mental disorders PHARMACOPSYCHIATRY. 2008 SEP; 41: S2-S18	0	2	1	127
4282	557 Mobach MP From the laboratory to pharmaceutical care research - Part I PHARMACY WORLD & SCIENCE. 2001 DEC; 23 (6): 205-209	0	6	2	33
4283	1531 Bruggeman FJ, Westerhoff HV, Boogerd FC BioComplexity: a pluralist research strategy is necessary for a mechanistic explanation of the "live" state PHILOSOPHICAL PSYCHOLOGY. 2002 DEC; 15 (4): 411-440	0	7	3	89
4284	1170 Swindells M, Rae M, Pearce M, Moodie S, Miller R, et al. Application of high-throughput computing in bioinformatics PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES. 2002 JUN 15; 360 (1795): 1179-1189	0	6	2	11
4285	2043 Vendruscolo M, Zurdo J, MacPhee CE, Dobson CM Protein folding and misfolding: a paradigm of self-assembly and regulation in complex biological systems PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES. 2003 JUN 13; 361 (1807): 1205-1222	0	35	3	65
4286	2044 Pawson T Organization of cell-regulatory systems through modular-protein-interaction domains PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES. 2003 JUN 13; 361 (1807): 1251-1262	0	11	4	53
4287	4717 Fenner JW, Brook B, Clapworthy G, Coveney PV, Feipel V, et al. The EuroPhysiome, STEP and a roadmap for the virtual physiological human PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES. 2008 SEP 13; 366 (1878): 2979-2999	0	15	7	71
4288	5014 Armstrong JD, van Hemert JI Towards a virtual fly brain PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES. 2009 JUN 13; 367 (1896): 2387-2397	0	1	1	37
4289	5115 Bickel PJ, Brown JB, Huang HY, Li QH An overview of recent developments in genomics and associated statistical methods PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES. 2009 NOV 13; 367 (1906): 4313-4337	0	1	5	114
4290	798 Turner M, Blackwell J, Newbold C, Vickerman K Utilizing the genome sequence of parasitic protozoa - Introduction PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2002 JAN 29; 357 (1417): 3-4	0	0	2	3
#	Date / Author / Journal	LCS	GCS	LCR	CR
4291	799 Carucci DJ Technologies for the study of gene and protein expression in Plasmodium PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2002 JAN 29; 357 (1417): 13-16	1	3	2	12
4292	800 Oliver SG Functional genomics: lessons from yeast PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2002 JAN 29; 357 (1417): 17-23	1	31	3	58
4293	1020 Furlong RF, Holland PWH Were vertebrates octoploid? PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2002 APR 29; 357 (1420): 531-544	10	98	2	118
4294	1179 Bevan M Genomics and plant cells: application of genomics strategies to Arabidopsis cell biology PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2002 JUN 29; 357 (1422): 731-736	0	7	2	24
4295	3418 Willard HF, Angrist M, Ginsburg GS Genomic medicine: genetic variation and its impact on the future of health care PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2005 AUG 22; 360 (1460): 1543-1550	0	11	8	78
4296	3759 Oliver SG From genomes to systems: the path with yeast PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2006 MAR 29; 361 (1467): 477-482	0	16	2	53
4297	4280 Yu J, Wong GKS, Liu SQ, Wang JA, Yang HM A comprehensive crop genome research project: the superhybrid rice genome project in China PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2007 JUN 29; 362 (1482): 1023-1034	0	3	11	63
4298	4584 Copley RR The animal in the genome: comparative genomics and evolution PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2008 APR 27; 363 (1496): 1453-1461	2	5	13	88
4299	315 Ankeny RA Model organisms as models: Understanding the 'lingua franca' of the Human Genome Project PHILOSOPHY OF SCIENCE. 2001 SEP; 68 (3): S251-S261	0	9	2	42
4300	3137 Narang P, Bhushan K, Bose S, Jayaram B A computational pathway for bracketing native-like structures for small alpha helical globular proteins PHYSICAL CHEMISTRY CHEMICAL PHYSICS. 2005; 7 (11): 2364-2375	0	12	1	181

Date / Author / Journal

LCS

GCS

LCR

4201

1653 Savage SA, Chanock S

Genetic variation and hematopoietic stem cell transplantation: expansion of the paradigm

PEDIATRIC TRANSPLANTATION. 2003; 7: 32-39

4202

2453 Estephan R, Arevalo E, Becker JM, Naider F

Biosynthesis of the sixth transmembrane domain of the Saccharomyces cerevisiae alpha-factor receptor

PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS. 2004; : 754-755

4203

835 Conlon JM

The origin and evolution of peptide YY (PYY) and pancreatic polypeptide (PP)

PEPTIDES. 2002 FEB; 23 (2): 269-278

4204

3375 Hand D, Eiden LE

Human sorbin is generated via splicing of an alternative transcript from the ArgBP2 gene locus

PEPTIDES. 2005 JUL; 26 (7): 1278-1282

4205

4409 Pimenta DC, Lebrun I

Cryptides: Buried secrets in proteins

PEPTIDES. 2007 DEC; 28 (12): 2403-2410

4206

909 Curlin M, Kostovic-Knezevic L, Gajovic S

Gene trap mutagenesis of three genes expressed during mouse embryo development

PERIODICUM BIOLOGORUM. 2002 MAR; 104 (1): 47-54

4207

2766 Plohl M, Bruvo B, Mestrovic N, Mravinac B, Petrovic V, et al.

Satellite DNA sequences in centromeric heterochromatin

PERIODICUM BIOLOGORUM. 2004 JUN; 106 (2): 95-102

4208

3543 Zinic SD

SitaRam: a computational approach for multi perspective visualization of higher-order and progressive patterns in highly repetitive regions of DNA

PERIODICUM BIOLOGORUM. 2005 DEC; 107 (4): 423-436

4209

703 Schenkein HA

Finding genetic risk factors for periodontal diseases: is the climb worth the view?

PERIODONTOLOGY 2000. 2002; 30: 79-90

4210

3635 Slavkin HC, Bartold PM

Challenges and potential in tissue engineering

PERIODONTOLOGY 2000. 2006; 41: 9-15

Date / Author / Journal

LCS

GCS

LCR

4211

3813 White TJ, Clark AG, Broder S

Genome-based biomarkers for adverse drug effects, patient enrichment and prediction of drug response, and their incorporation into clinical trial design

PERSONALIZED MEDICINE. 2006 MAY; 3 (2): 177-185

4212

4310 Subbiab MTR

Personalizing our diet to improve our health: the potential impact of nutrigenomics

PERSONALIZED MEDICINE. 2007 AUG; 4 (3): 233-236

4213

4549 Farrell E, Usuka J

Pharmacogenomics and drug development: the impact of US FDA postapproval tracking on clinical pharmacology

PERSONALIZED MEDICINE. 2008 MAR; 5 (2): 133-139

4214

5107 Wagner MJ

Pharmacogenetics and personal genomes

PERSONALIZED MEDICINE. 2009 NOV; 6 (6): 643-652

4215

380 Gest H

Evolution of knowledge encapsulated in scientific definitions

PERSPECTIVES IN BIOLOGY AND MEDICINE. 2001 FAL; 44 (4): 556-564

4216

1390 Hunter P, Robbins P, Noble D

The IUPS human physiome project

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY. 2002 OCT; 445 (1): 1-9

4217

3268 Soutourina O, Cheval L, Doucet A

Global analysis of gene expression in mammalian kidney

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY. 2005 APR; 450 (1): 13-25

4218

1530 Chin KV, Kong ANT

Application of DNA Microarrays in pharmacogenomics and toxicogenomics

PHARMACEUTICAL RESEARCH. 2002 DEC; 19 (12): 1773-1778

4219

1716 Anderle P, Rakhmanova V, Woodford K, Zerangue N, Sadee W

Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines

PHARMACEUTICAL RESEARCH. 2003 JAN; 20 (1): 3-15

4220

556 Freimuth RR, Eckloff B, Wieben ED, Weinshilboum RM

Human sulfotransferase SULT1C1 pharmacogenetics: gene resequencing and functional genomic studies

PHARMACOGENETICS. 2001 DEC; 11 (9): 747-756

Date / Author / Journal

LCS

GCS

LCR

4221

757 Xu ZH, Freimuth RR, Eckloff B, Wieben E, Weinshilboum RM

Human 3 '-phosphoadenosine 5 '-phosphosulfate synthetase 2 (PAPSS2) pharmacogenetics: gene resequencing, genetic polymorphisms and functional characterization of variant allozymes

PHARMACOGENETICS. 2002 JAN; 12 (1): 11-21

4222

1717 Liljedahl U, Karlsson J, Melhus H, Kurland L, Lindersson M, et al.

A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response

PHARMACOGENETICS. 2003 JAN; 13 (1): 7-17

4223

2502 Nelson DR, Zeldin DC, Hoffman SMG, Maltais LJ, Wain HM, et al.

Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants

PHARMACOGENETICS. 2004 JAN; 14 (1): 1-18

194

4224

2767 Tetlow N, Robinson A, Mantle J, Board P

Polymorphism of human mu class glutathione transferases

PHARMACOGENETICS. 2004 JUN; 14 (6): 359-368

4225

2860 Hillman MA, Wilke RA, Caldwell MD, Berg RL, Glurich I, et al.

Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype

PHARMACOGENETICS. 2004 AUG; 14 (8): 539-547

4226

3335 Busi F, Cresteil T

Phenotyping-genotyping of alternatively spliced genes in one step: study of CYP3A5*3 polymorphism

PHARMACOGENETICS AND GENOMICS. 2005 JUN; 15 (6): 433-439

4227

3544 Gratz M, Kunert-Keil C, John U, Cascorbi I, Kroemer HK

Identification and functional analysis of genetic variants of the human beta-glucuronidase in a German population sample

PHARMACOGENETICS AND GENOMICS. 2005 DEC; 15 (12): 875-881

4228

4792 Krzywkowski K, Davies PA, Irving AJ, Brauner-Osborne H, Jensen AA

Characterization of the effects of four HTR3B polymorphisms an human 5-HT3AB receptor expression and signalling

PHARMACOGENETICS AND GENOMICS. 2008 DEC; 18 (12): 1027-1040

4229

242 Sham P

Shifting paradigms in gene-mapping methodology for complex traits

PHARMACOGENOMICS. 2001 AUG; 2 (3): 195-202

4230

243 Huang S

Genomics, complexity and drug discovery: insights from Boolean network models of cellular regulation

PHARMACOGENOMICS. 2001 AUG; 2 (3): 203-222

Date / Author / Journal

LCS

GCS

LCR

4231

758 Shilling PD, Kelsoe JR

Functional genomics approaches to understanding brain disorders

PHARMACOGENOMICS. 2002 JAN; 3 (1): 31-45

4232

910 Dandekar T, Sauerborn R

Comparative genome analysis and pathway reconstruction

PHARMACOGENOMICS. 2002 MAR; 3 (2): 245-256

4233

911 Pettipher R, Cardon LR

The application of genetics to the discovery of better medicines

PHARMACOGENOMICS. 2002 MAR; 3 (2): 257-263

4234

1063 Judson R, Salisbury B, Schneider J, Windemuth A, Stephens JC

How many SNPs does a genome-wide haplotype map require?

PHARMACOGENOMICS. 2002 MAY; 3 (3): 379-391

4235

1064 Balasubramanian S, Harrison P, Hegyi H, Bertone P, Luscombe N, et al.

SNPs on human chromosomes 21 and 22 - analysis in terms of protein features and pseudogenes

PHARMACOGENOMICS. 2002 MAY; 3 (3): 393-402

4236

1330 Thallinger GG, Trajanoski S, Stocker G, Trajanoski Z

Information management systems for pharmacogenomics

PHARMACOGENOMICS. 2002 SEP; 3 (5): 651-667

4237

1331 Obata K, Tajima H, Yohda M, Matsunaga T

Recent developments in laboratory automation using magnetic particles for genome analysis

PHARMACOGENOMICS. 2002 SEP; 3 (5): 697-708

4238

1454 Willett JD

Genomics, proteomics: what's next

PHARMACOGENOMICS. 2002 NOV; 3 (6): 727-728

4239

1455 Dixon AK, Lee K, Richardson PJ, Bell MI, Skynner MJ

Single cell expression analysis - pharmacogenomic potential

PHARMACOGENOMICS. 2002 NOV; 3 (6): 809-822

4240

1837 Slavkin HC

Applications of pharmacogenomics in general dental practice

PHARMACOGENOMICS. 2003 MAR; 4 (2): 163-170

Date / Author / Journal

4241

Haplotypes and the systematic analysis of genetic variation in genes and genomes

PHARMACOGENOMICS. 2003 SEP; 4 (5): 547-570

106

4242

2943 Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, et al.

Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population

PHARMACOGENOMICS. 2004 OCT; 5 (7): 895-931

4243

3244 Yengi LG

Systems biology in drug safety and metabolism: integration of microarray, real-time PCR and enzyme approaches

PHARMACOGENOMICS. 2005 MAR; 6 (2): 185-192

4244

3269 Lorenzi C, Mandelli L, Pirovano A, Ploia C, Insacco C, et al.

The XIIth World Congress of Psychiatric Genetics

PHARMACOGENOMICS. 2005 APR; 6 (3): 199-204

4245

3336 Bennett ST, Barnes C, Cox A, Davies L, Brown C

Toward the $1000 human genome

PHARMACOGENOMICS. 2005 JUN; 6 (4): 373-382

4246

4126 Kimchi-Sarfaty C, Marple AH, Shinar S, Kimchi AM, Scavol D, et al.

PHARMACOGENOMICS. 2007 JAN; 8 (1): 29-39

4247

4234 Crawford DC, Ritchie MD, Rieder MJ

Identifying the genotype phenotype: a role model behind the found in VKORC1 and its association with warfarin dosing

PHARMACOGENOMICS. 2007 MAY; 8 (5): 487-496

4248

4268 Lal S, Wong ZW, Jada SR, Xiang XQ, Shu XC, et al.

Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients

PHARMACOGENOMICS. 2007 JUN; 8 (6): 567-575

4249

4385 Gurwitz D, Motulsky AG

'Drug reactions, enzymes, and biochemical genetics': 50 years later

PHARMACOGENOMICS. 2007 NOV; 8 (11): 1479-1484

4250

4520 Oertel B, Lotsch J

Genetic mutations that prevent pain: implications for future pain medication

PHARMACOGENOMICS. 2008 FEB; 9 (2): 179-194

113

Date / Author / Journal

LCS

GCS

LCR

4251

4605 Zhang W, Dolan ME

PHARMACOGENOMICS. 2008 MAY; 9 (5): 489-492

4252

4924 Wang HH, Liao YW, Chiang HL, Wu JY, Chen YT

Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population

PHARMACOGENOMICS. 2009 MAR; 10 (3): 359-374

4253

4925 Gennari L, Merlotti D, De Paola V, Martini G, Nuti R

Update on the pharmacogenetics of the vitamin D receptor and osteoporosis

PHARMACOGENOMICS. 2009 MAR; 10 (3): 417-433

132

4254

4977 Gagna CE, Lambert WC

Novel multistranded, alternative, plasmid and helical transitional DNA and RNA microarrays: implications for therapeutics

PHARMACOGENOMICS. 2009 MAY; 10 (5): 895-914

4255

5086 Abdel-Hamid IA, Andersson KE

Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications

PHARMACOGENOMICS. 2009 OCT; 10 (10): 1625-1644

174

4256

1654 Scherl E, Frissora CL

Irritable bowel syndrome genophenomics: correlation of serotonin-transporter polymorphisms and alosetron response

PHARMACOGENOMICS JOURNAL. 2003; 3 (2): 64-66

4257

1655 Chen X, Sullivan PF

Single nucleotide polymorphism genotyping: biochemistry, protocol, cost and throughput

PHARMACOGENOMICS JOURNAL. 2003; 3 (2): 77-96

134

4258

3478 Freebern WJ, Haggerty CM, Montano I, McNutt MC, Collins I, et al.

Pharmacologic profiling of transcriptional targets deciphers promoter logic

PHARMACOGENOMICS JOURNAL. 2005 OCT; 5 (5): 305-323

4259

3814 Farahani P, Levine M

Pharmacovigilance in a genomic era

PHARMACOGENOMICS JOURNAL. 2006 MAY; 6 (3): 158-161

4260

3945 Weiss ST, Litonjua AA, Lange C, Lazarus R, Liggett SB, et al.

Overview of the pharmacogenetics of asthma treatment

PHARMACOGENOMICS JOURNAL. 2006 SEP-OCT; 6 (5): 311-326

105

Date / Author / Journal

LCS

GCS

LCR

4261

4901 Passetti F, Ferreira CG, Costa FF

The impact of microRNAs and alternative splicing in pharmacogenomics

PHARMACOGENOMICS JOURNAL. 2009 FEB; 9 (1): 1-13

134

4262

2661 Meloni R, Khalfallah O, Biguet NF

DNA microarrays and pharmacogenomics

PHARMACOLOGICAL RESEARCH. 2004 APR; 49 (4): 303-308

4263

2662 Trotta R, Donati MB, Iacoviello L

Trends in pharmacogenomics of drugs acting on hypertension

PHARMACOLOGICAL RESEARCH. 2004 APR; 49 (4): 351-356

4264

4333 Kim HR, Park SW, Cho HJ, Chae KA, Sung JM, et al.

Comparative gene expression profiles of intestinal transporters in mice, rats and humans

PHARMACOLOGICAL RESEARCH. 2007 SEP; 56 (3): 224-236

108

4265

4902 de Leon J

The future (or lack of future) of personalized prescription in psychiatry

PHARMACOLOGICAL RESEARCH. 2009 FEB; 59 (2): 81-89

4266

912 Schrem H, Klempnauer J, Borlak J

Liver-enriched transcription factors in liver function and development. Part I: The hepatocyte nuclear factor network and liver-specific gene expression

PHARMACOLOGICAL REVIEWS. 2002 MAR; 54 (1): 129-158

261

4267

2196 Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y

Impact of drug transporter studies on drug discovery and development

PHARMACOLOGICAL REVIEWS. 2003 SEP; 55 (3): 425-461

169

387

4268

3245 Kreek MJ, Bart G, Lilly C, Laforge KS, Nielsen DA

Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments

PHARMACOLOGICAL REVIEWS. 2005 MAR; 57 (1): 1-26

300

4269

244 Yuan J, Liu Y, Wang YH, Xie GC, Blevins R

Genome analysis with gene-indexing databases

PHARMACOLOGY & THERAPEUTICS. 2001 AUG; 91 (2): 115-132

4270

836 Davies TG, Pratt DJ, Endicott JA, Johnson LN, Noble MEM

Structure-based design of cyclin-dependent kinase inhibitors

PHARMACOLOGY & THERAPEUTICS. 2002 FEB-MAR; 93 (2-3): 125-133

Date / Author / Journal

LCS

GCS

LCR

4271

837 Yeh RH, Lee TR, Lawrence DS

From consensus sequence to high-affinity ligands: acquisition of signaling protein modulators

PHARMACOLOGY & THERAPEUTICS. 2002 FEB-MAR; 93 (2-3): 179-191

4272

2143 Carroll PM, Dougherty B, Ross-Macdonald P, Browman K, FitzGerald K

Model systems in drug discovery: chemical genetics meets genomics

PHARMACOLOGY & THERAPEUTICS. 2003 AUG; 99 (2): 183-220

340

4273

2718 Roth BL, Lopez E, Beischel S, Westkaemper RB, Evans JM

Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery

PHARMACOLOGY & THERAPEUTICS. 2004 MAY; 102 (2): 99-110

4274

2768 Kostenis E

A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands

PHARMACOLOGY & THERAPEUTICS. 2004 JUN; 102 (3): 243-257

162

4275

3337 Krause CD, Pestka S

Evolution of the Class 2 cytokines and receptors, and discovery of new friends and relatives

PHARMACOLOGY & THERAPEUTICS. 2005 JUN; 106 (3): 299-346

206

4276

3407 Efferth T, Volm M

Pharmacogenetics for individualized cancer chemotherapy

PHARMACOLOGY & THERAPEUTICS. 2005 AUG; 107 (2): 155-176

289

4277

3479 Roth BL

Receptor systems: Will mining the receptorome yield novel targets for pharmacotherapy?

PHARMACOLOGY & THERAPEUTICS. 2005 OCT; 108 (1): 59-64

4278

3815 Millan MJ

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

PHARMACOLOGY & THERAPEUTICS. 2006 MAY; 110 (2): 135-370

3729

4279

3889 Judge SI, Bever CT

Potassium channel blockers in multiple sclerosis: Neuronal K-V channels and effects of symptomatic treatment

PHARMACOLOGY & THERAPEUTICS. 2006 JUL; 111 (1): 224-259

429

4280

5087 Horstmann S, Binder EB

Pharmacogenomics of antidepressant drugs

PHARMACOLOGY & THERAPEUTICS. 2009 OCT; 124 (1): 57-73

226

Date / Author / Journal

LCS

GCS

LCR

4281

4709 Tretter F, Albus M

Systems biology and psychiatry - Modeling molecular and cellular networks of mental disorders

PHARMACOPSYCHIATRY. 2008 SEP; 41: S2-S18

127

4282

557 Mobach MP

From the laboratory to pharmaceutical care research - Part I

PHARMACY WORLD & SCIENCE. 2001 DEC; 23 (6): 205-209

4283

1531 Bruggeman FJ, Westerhoff HV, Boogerd FC

BioComplexity: a pluralist research strategy is necessary for a mechanistic explanation of the "live" state

PHILOSOPHICAL PSYCHOLOGY. 2002 DEC; 15 (4): 411-440

4284

1170 Swindells M, Rae M, Pearce M, Moodie S, Miller R, et al.

Application of high-throughput computing in bioinformatics

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES. 2002 JUN 15; 360 (1795): 1179-1189

4285

2043 Vendruscolo M, Zurdo J, MacPhee CE, Dobson CM

Protein folding and misfolding: a paradigm of self-assembly and regulation in complex biological systems

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES. 2003 JUN 13; 361 (1807): 1205-1222

4286

2044 Pawson T

Organization of cell-regulatory systems through modular-protein-interaction domains

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES. 2003 JUN 13; 361 (1807): 1251-1262

4287

4717 Fenner JW, Brook B, Clapworthy G, Coveney PV, Feipel V, et al.

The EuroPhysiome, STEP and a roadmap for the virtual physiological human

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES. 2008 SEP 13; 366 (1878): 2979-2999

4288

5014 Armstrong JD, van Hemert JI

Towards a virtual fly brain

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES. 2009 JUN 13; 367 (1896): 2387-2397

4289

5115 Bickel PJ, Brown JB, Huang HY, Li QH

An overview of recent developments in genomics and associated statistical methods

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES. 2009 NOV 13; 367 (1906): 4313-4337

114

4290

798 Turner M, Blackwell J, Newbold C, Vickerman K

Utilizing the genome sequence of parasitic protozoa - Introduction

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2002 JAN 29; 357 (1417): 3-4

Date / Author / Journal

4291

Technologies for the study of gene and protein expression in Plasmodium

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2002 JAN 29; 357 (1417): 13-16

4292

800 Oliver SG

Functional genomics: lessons from yeast

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2002 JAN 29; 357 (1417): 17-23

4293

1020 Furlong RF, Holland PWH

Were vertebrates octoploid?

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2002 APR 29; 357 (1420): 531-544

118

4294

1179 Bevan M

Genomics and plant cells: application of genomics strategies to Arabidopsis cell biology

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2002 JUN 29; 357 (1422): 731-736

4295

3418 Willard HF, Angrist M, Ginsburg GS

Genomic medicine: genetic variation and its impact on the future of health care

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2005 AUG 22; 360 (1460): 1543-1550

4296

3759 Oliver SG

From genomes to systems: the path with yeast

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2006 MAR 29; 361 (1467): 477-482

4297

4280 Yu J, Wong GKS, Liu SQ, Wang JA, Yang HM

A comprehensive crop genome research project: the superhybrid rice genome project in China

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2007 JUN 29; 362 (1482): 1023-1034

4298

4584 Copley RR

The animal in the genome: comparative genomics and evolution

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2008 APR 27; 363 (1496): 1453-1461

4299

315 Ankeny RA

Model organisms as models: Understanding the 'lingua franca' of the Human Genome Project

PHILOSOPHY OF SCIENCE. 2001 SEP; 68 (3): S251-S261

4300

3137 Narang P, Bhushan K, Bose S, Jayaram B

A computational pathway for bracketing native-like structures for small alpha helical globular proteins

PHYSICAL CHEMISTRY CHEMICAL PHYSICS. 2005; 7 (11): 2364-2375

181

The sequence of the human genome (Venter) The papers citing Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, et al. "The sequence of the human genome." SCIENCE. 2001 FEB 16; 291 (5507): 1304	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 18020, GCS 180410, CR 319862 Collection span: 2000 - 2010
List of All Records